Blood tests that detect early cancer are coming to market. Could they lead to earlier diagnosis and treatment?

CrowdStrike President Michael Sentonas said the purchase of Israel-based Adaptive Shield is “essential” for the company’s future in SaaS and artificial intelligence security. “Our ...